ORIGINAL RESEARCH
Accepted on 05 Feb 2025
Expression of SIRPα-Fc by Oncolytic Virus Enhances Antitumor Efficacy through Tumor Microenvironment Reprogramming
doi 10.3389/fimmu.2025.1513555
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Vector-Based Gene Delivery in Cancer Immunotherapy
Vector-Based Gene Delivery in Cancer Immunotherapy
4,514
Total downloads
14k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 26 Jun 2024
Non-viral-mediated gene transfer of OX40 ligand for tumor immunotherapy
doi 10.3389/fimmu.2024.1410564
- 1,715 views
- 1 citation
REVIEW
Published on 13 May 2024
Intratumoral delivery of immunotherapy to treat breast cancer: current development in clinical and preclinical studies
doi 10.3389/fimmu.2024.1385484
- 3,492 views
- 2 citations
REVIEW
Published on 26 Apr 2023
Recent advances in oncolytic virus therapy for hepatocellular carcinoma
doi 10.3389/fonc.2023.1172292
- 3,904 views
- 9 citations
ORIGINAL RESEARCH
Published on 29 Mar 2023
A recombinant adenovirus vector containing the synNotch receptor gene for the treatment of triple-negative breast cancer
doi 10.3389/fonc.2023.1147668
- 2,455 views
- 2 citations
Published in
Frontiers in Immunology
- Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Impact
- 14kTopic views
- 9,382Article views
- 4,514Article downloads